[Imidazole receptors: site of action of a new generation of antihypertensive drugs. Current status and future prospects].
Molderings
G J
GJ
Institut für Pharmakologie und Toxikologie, Universität Bonn.
Michel
M C
MC
Göthert
M
M
Christen
O
O
Schäfer
S G
SG
D000316:Adrenergic alpha-Agonists; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001665:Binding Sites; D002417:Cattle; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D010080:Oxazoles / Q000494:pharmacology; D051381:Rats; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects; D011955:Receptors, Drug / Q000187:drug effects; D000077769:Rilmenidine
D000316:Adrenergic alpha-Agonists; D000959:Antihypertensive Agents; D007093:Imidazoles; D010080:Oxazoles; D011942:Receptors, Adrenergic, alpha; D011955:Receptors, Drug; C043482:moxonidine; D000077769:Rilmenidine
Imidazolrezeptoren: Angriffsort einer neuen Generation von antihypertensiven Arzneimitteln. Aktueller Stand und Zukunftsperspektiven.